Financials
Financial year 2025
RHUMEDIC from Sombreffe, company number BE0799181515, closed financial year 2025 with a result of € 70,373 after tax. For that financial year RHUMEDIC recorded a gross margin of € 90,829 and equity of € 169,118. Compared with financial year 2024, the result moved from € 69,351 to € 70,373. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 11, 2026.
€ 169,118
▲ 70% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 70,373
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 140,848
▲ 61% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,017
▲ 94% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 836
Loans from banks and other lenders, long and short.
€ 8,366
▲ € 8,243 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,087
▼ 31% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 41,155 | € 88,995 | € 90,829 | ▲ 2% |
| Profit after taxes | € 28,919 | € 69,351 | € 70,373 | ▲ 1% |
| Equity | € 31,086 | € 99,578 | € 169,118 | ▲ 70% |
| Total debts | € 9,503 | € 28,433 | € 29,528 | ▲ 4% |
| Cash | € 21,140 | € 87,551 | € 140,848 | ▲ 61% |
| Retained profit | € 28,086 | € 96,578 | € 166,118 | ▲ 72% |
| Dividend | € 833 | € 859 | € 833 | ▼ 3% |
| Bank debt | € 0 | € 0 | € 836 | |
| Balance sheet total | € 40,589 | € 128,011 | € 198,646 | ▲ 55% |
Key figures of RHUMEDIC, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to RHUMEDIC?
What happened at RHUMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 70,373 (▲ 1% vs 2024). filed late Source: NBB ↗
- New establishment in Sombreffe. KBO
- Start of the company according to the CBE. KBO
In short
From € 28,919 profit in 2023 to € 70,373 profit in 2025.
Paid € 46,469 in corporate taxes since 2023.
Best year ever: 2025, with € 70,373 profit.
Paid out € 2,525 in dividends to the owners in total.
A new publication or filing at RHUMEDIC? We notify you, reason included.
Follow RHUMEDICDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind RHUMEDIC is Emilie Sapart. Emilie Sapart is also behind SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE.
Directors
According to the 2025 annual accounts
Emilie Sapart
Managing director
Also active at: SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE
Establishments
Establishment units
Physical locations of this company
Rue de Wavre 28
5140 Sombreffe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0799.181.515
- VAT number
- BE 0799.181.515
- Registered office
- Rue de Wavre 28, 5140 Sombreffe
- Names & denominations
- RHUMEDIC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 March 2023
- Peppol
- Active · Active since 14 Jun 2025
- Activities · NACE
Activiteiten van medisch specialisten